Anika Makes Senior Appointments
This article was originally published in Scrip
Executive Summary
Anika Therapeutics Inc., a US-based integrated orthopedic medicines business, has appointed Stephen Mascioli chief medical officer (CMO) and Dana Alexander to the role of chief operations officer. Jean Bjerke has also joined the company as vice president of marketing. Mascioli has over 25 years of leadership experience, having previously held the inaugural CMO position at Terumos Americas Holdings, before which he served as CMO of the vascular therapies division of Covidien, a global medical device company. Alexander has spent the last 14 years in various leadership roles at Genzyme Corp., where he most recently served as senior director of biologics manufacturing operations. Bjerke brings 15 years' of marketing expertise to the role, having specialized in the orthopedic device segments for Smith & Nephew and DePuy Orthopaedics prior to joining Anika.
You may also be interested in...
Big Pharma's Bad Attitude: Are CEOs Giving Industry A Bad Rep?
Big pharma has been big news recently, with politicians and the general public wading into industry debates on drug pricing, profit-making and trial transparency under the gleeful eye of the international press. Unsurprisingly, pharma has come out on the losing side of these debates, its scientific accomplishments forced into the shadows by the actions of executives such as Martin Shkreli, who have ensured that the spotlight is firmly on the people behind the businesses rather than the products they manufacture.
Pfizer's Martine J. George joins GarmaMabs
GarmaMabs Pharma has appointed Martine J. George an independent board member.
Mylan Appoints Kenneth Parks CFO
Mylan has appointed Kenneth Parks chief financial officer (CFO).